Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Monday, 19 June 2017

Extrodinary General Shareholders' Meeting

MDxHealth (R)    

Published: 14:30 CEST 19-06-2017 /GlobeNewswire /Source: MDxHealth (R) / : MDXH /ISIN: BE0003844611

Extrodinary General Shareholders' Meeting


NEWS RELEASE                                                                                        




IRVINE, CA, and HERSTAL, BELGIUM - 14:30 CEST, June 19 2017 - MDxHealth SA (Euronext: MDXH.BR) held today its Extraordinary General Shareholders' Meeting in Brussels. The shareholders approved all agenda items of the Extraordinary General Shareholders' Meeting.



About MDxHealth

MDxHealth is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The company's tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, and prediction of response to a specific therapy. The Company's European headquarters are in Herstal, Belgium, with laboratory operations in Nijmegen, The Netherlands, and US headquarters and laboratory operations based in Irvine, California. For more information, visit mdxhealth.com and follow us on social media at: twitter.com/mdxhealth, facebook.com/mdxhealth and linkedin.com/company/mdxhealth.


For more information:


Jean-Marc Roelandt, Chief Financial Officer


+32 (0) 4 364 20 70




NOTE: The MDxHealth logo, MDxHealth, ConfirmMDx, SelectMDx, AssureMDx, PredictMDx and UrNCollect are trademarks or registered trademarks of MDxHealth SA. All other trademarks and service marks are the property of their respective owners.

MDxHealth EGSM press release

This announcement is distributed by Nasdaq Corporate Solutions (One Liberty Plaza, 165 Broadway, New York, NY 10006. Tel: +1 212 401 8700. www.nasdaqomx.com) on behalf of NASDAQ OMX Corporate Solutions clients. Source: MDxHealth (R), Rue d'Abhooz, 31, Herstal 4040, Belgique
If you would like to unsubscribe and stop receiving these e-mails click here.